Real-time enrollment status for this diabetic kidney disease (dkd) clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 5:42 AM UTC
| NCT Number | NCT07271186 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Kidney Disease (DKD) |
| Phase | PHASE2 |
| Target Enrollment | 270 participants |
| Active Locations | 58 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | August 10, 2026 (2 weeks ago) |
As of August 29, 2026: Clinical trial NCT07271186 is currently recruiting participants. This phase2 study for diabetic kidney disease (dkd) is actively seeking new participants at 58 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07271186 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 58 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07271186 was last updated 2 weeks ago (August 10, 2026). HelloStudys verifies this status automatically.